Published in

Current Opinion in Toxicology, (8), p. 8-13

DOI: 10.1016/j.cotox.2017.11.010

Links

Tools

Export citation

Search in Google Scholar

Aryl hydrocarbon receptor and liver fibrosis

Journal article published in 2018 by Caroline Duval, Etienne Blanc, Xavier Coumoul ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The concept of toxicant-associated liver disease (TALD) has recently emerged linking exposure to pollutants to the development of chronic liver diseases (CLD) including fibrosis. Among such pollutants, ligands of the Aryl hydrocarbon Receptor (AhR), a transcriptional factor involved in detoxification processes, have been suspected to trigger multiple mechanisms (oxidative stress, epithelial and mesenchymal transition) associated with the occurrence of such pathologies. However, AhR knockout-mice also could develop liver fibrosis, an observation which might first be described as a paradox. In this review, we will present the different mechanisms linking AhR ligands and CLD and provide a hypothesis to solve this paradox.